LifeArc and the UK Dementia Research Institute (UK DRI) have launched a new partnership to accelerate development of new diagnostic tests, treatments, and devices from scientific research discoveries to benefit people with dementia, which around 900,000 people in the UK are living with. At the heart of the five-year partnership is a £30 million commitment by medical research charity LifeArc to the UK DRI to support dementia research at six UK host universities...

Matrix Stability, Autoscribe Informatics’ software solution for managing stability and shelf-life studies is to be demonstrated at the Stability VI Symposia hosted by the Royal Society of Chemistry (RSC) in London. Matrix Stability provides a complete stability management system. Users can create stability protocols that define all required stability study attributes including pull schedules, cycles, storage conditions and test requirements for specific batches...

University Hospital Southampton (UHS) NHS Foundation Trust has signed a commercial collaboration agreement with Automata to develop new applications for laboratory automation technology. Automata is a London based biotech company providing robotic automation solutions to the life sciences industry. Comprising proprietary hardware, single-platform software and a world-class service, Automata partners with labs to take the hassle out of automation, empowering them to achieve more reliable results faster than ever before....

Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, today formally introduced its first portfolio company, Global Access Diagnostics (GADx). GADx has been created to address gaps in the global provision of diagnostics with a focus on expanding affordable access to quality tests. The Company combines expertise in rapid diagnostics development from Mologic Ltd with low-cost manufacturing and scale-up capability of sister company, Global Access Diagnostics (GAD)...

An excellent mood in five halls, delighted faces and many lively discussions at the exhibition booths: At analytica 2022, the international laboratory industry met again in person from June 21 to 24 in Munich. At the world’s leading trade fair, 891 exhibitors presented their innovations for the entire range of laboratory and analytics technology, life sciences and biotechnology to around 26,000 visitors...

The world's first electron diffractometer offers measurement results of unprecedented quality for the pharmaceutical, electromobility and new materials sectors. The Experience Center for Electron Diffraction has now started operations in Basel-Allschwil. The Swiss company ELDICO Scientific operates the world's first electron diffractometer there...

Matrix Diagnostics – a dedicated COVID-19 testing lab in California – is relying on INTEGRA Biosciences’ EVOLVE and MINI 96 pipettes to streamline and accelerate its PCR workflows. Founded in January 2021 to meet the growing demand for testing in the San Francisco Bay Area, Matrix Diagnostics is using these user-friendly and cost-effective solutions to test up to 5000 samples a day...

The autoclaves from Systec GmbH can be used for all laboratory applications: for sterilizing solids, liquids, waste, and biological hazardous substances. All autoclaves can be equipped with options to optimize the sterilization process. The options required for the corresponding sterilization processes can be added to your configuration. When sterilizing solids and waste in bags, for example, Systec autoclaves can be equipped with a vacuum system that completely removes the air from the product...

Evident, a wholly owned subsidiary of Olympus Corporation, is proud to announce that its Olympus Provi™ CM20 incubation monitoring system is the 2022 recipient of the prestigious "Best of the Best" award in the Product Design category of the Red Dot Design Award. This Award is bestowed on a product that the Red Dot Jury deems as groundbreaking and is the highest honor given in this world-renowned design competition...

At the fair, MolGen presents the PurePrep 24, an DNA/RNA extraction system for high sample volume applications, such as isolating DNA from blood samples. The PurePrep 4800 is a complete DNA/RNA extraction system with sample barcode scanning, liquid handling for reagents and samples, extraction and PCR setup in one system. The newest MolGen testing device is MoaA RT. This multiplex viruses RT-qPCR kit is a single well, which targets 5 highly infectious diseases..

INTEGRA Biosciences’ electronic handheld pipetting solutions are helping to improve the throughput capacity of bulk RNA barcoding and sequencing (BRB-seq) at Alithea Genomics in Switzerland. The company’s fast, high throughput and robust in-house BRB-seq service provides crucial gene expression data at a fraction of the cost and time of traditional RNA-seq, and the company’s workflow relies on INTEGRA VIAFLO 96 and VIAFLO 384 electronic handheld pipettes to provide the speed and precision needed for seamless plate-to-plate transfers...

DataApex is pleased to announce that a new control module for the Nexera LC-40 HPLC system has been released! It is a part of Clarity - Shimadzu Edition Chromatography Software that is dedicated to the European market. Customers can use a control module for the Nexera LC-40 HPLC system in combination with hundreds of instruments supported in Clarity, including the Shimadzu Nexis GC-2030....

Merck, a leading science and technology company, has signed an agreement with the Administrative Management Committee of Wuxi National High-Tech Industrial Development Zone to significantly expand Merck’s first Asia-Pacific Mobius® Single-Use manufacturing center in China. For more than two decades, Merck’s Life Science business sector...

A partnership between antibody development experts and global healthcare providers creates a new COVID-19 treatment for immunocompromised, high-risk, and vaccine refractory individuals, effective against major variants including Omicron. ProteoGenix(market-leading antibody provider), Aseem Healthcare (global healthcare company), and Trident Biopharm Solutions (life science consultancy agency)...

Hyperpolarized water boosts signal intensities of proteins, DNA and membranes. A small group of researchers including Dennis Kurzbach from the Faculty of Chemistry of the University of Vienna just published in „Nature Protocols” an advanced NMR (Nuclear Magnetic Resonance) method to monitor fast and complicated biomolecular events such as protein folding...

Biosynth Carbosynth (“Biosynth”), a supplier of critical materials to the life science industry, announces the acquisition of Aalto Bio Reagents (“Aalto”), a leading developer and provider of biological materials to the in-vitro diagnostic (IVD) and vaccine development industry in the field of emerging disease. The acquisition represents a further milestone in Biosynth’s development, which broadens its capabilities and offering to the IVD industry...

The Rutherford Health group (the Group) which operates a network of cancer and diagnostic centres in the UK, announce that an application is to be made to place the Group into liquidation. Since 2015, Rutherford Health has built a network of oncology centres known as the Rutherford Cancer Centres which are located in South Wales, Northumberland, Liverpool and Thames Valley....

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, is pleased to announce that it has extended its collaboration agreement with PinotBio (Gyeonggi-do, Korea), a clinical-stage oncology-focused biotechnology company, to develop four new Optimer-drug conjugates for use as precision chemotherapeutics. The partnership was first initiated in June 2021 targeting haematological cancers...

Indica Labs, the leading provider of computational pathology software and services, is excited to announce a CE-IVD Mark for HALO Prostate AI, a deep learning-based screening tool designed to assist pathologists in identifying and grading prostate cancer in core needle biopsies. Prostate cancer is the most common cancer diagnosed in men. With over 1.4 million cases reported worldwide in 2020, the incidence rates continue to rise with wider availability of screening tests, such as PSA....